-

Rockwell Medical to Release Third Quarter 2024 Results on Monday, November 11, 2024

WIXOM, Mich.--(BUSINESS WIRE)--Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced that it will release its financial and operational results for the third quarter ended September 30, 2024 on Monday, November 11, 2024. The Company will issue a press release at 6:00am ET followed by a live conference call and webcast at 8:00am ET.

$RMTI to release its Q3'24 financial and operational results on Monday, November 11, 2024

Share

CONFERENCE CALL AND WEBCAST DETAILS

Date: Monday, November 11, 2024

Time: 8:00am ET

Live Number: (888) 660-6347 // (International) 1 (929) 201-6594

Conference Call ID: 4944610

Webcast and Replay: www.RockwellMed.com/Results

Format: Discussion of third quarter 2024 financial and operational results followed by Q&A.

ABOUT ROCKWELL MEDICAL

Rockwell Medical, Inc. (Nasdaq: RMTI) is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers worldwide. Rockwell Medical's mission is to provide dialysis clinics and the patients they serve with the highest quality products supported by the best customer service in the industry. Rockwell is focused on innovative, long-term growth strategies that enhance its products, its processes, and its people, enabling the Company to deliver exceptional value to the healthcare system and provide a positive impact on the lives of hemodialysis patients. Hemodialysis is the most common form of end-stage kidney disease treatment and is usually performed at freestanding outpatient dialysis centers, at hospital-based outpatient centers, at skilled nursing facilities, or in a patient’s home. Rockwell Medical's products are vital to vulnerable patients with end-stage kidney disease, and the Company is relentless in providing unmatched reliability and customer service. Certified as a Great Place to Work® in 2023 and 2024 and named Fortune Best Workplaces in Manufacturing & ProductionTM in 2024, Rockwell Medical is Driven to Deliver Life-Sustaining Dialysis SolutionsTM. For more information, visit www.RockwellMed.com.

Contacts

Heather R. Hunter
SVP, Chief Corporate Affairs Officer
(248) 432-1362
IR@RockwellMed.com

Rockwell Medical

NASDAQ:RMTI
Details
Headquarters: Wixom, MI
CEO: Mark Strobeck
Employees: 250
Organization: PUB
Revenues: 83,600,000 (2023)

Release Summary
Rockwell Medical will release its financial and operational results for the third quarter ended September 30, 2024 on Monday, November 11, 2024.
Release Versions
$Cashtags

Contacts

Heather R. Hunter
SVP, Chief Corporate Affairs Officer
(248) 432-1362
IR@RockwellMed.com

Social Media Profiles
More News From Rockwell Medical

Rockwell Medical Announces 1-for-10 Reverse Stock Split

WIXOM, Mich.--(BUSINESS WIRE)--Rockwell Medical's Board of Directors has authorized a 1-for-10 reverse split of the Company's issued and outstanding common stock....

Rockwell Medical Renews Product Purchase Agreement with aQua Dialysis

WIXOM, Mich.--(BUSINESS WIRE)--Rockwell Medical will supply aQua Dialysis with liquid and dry, acid and bicarbonate hemodialysis concentrates and other essential dialysis products....

Rockwell Medical Signs New 3-Year Product Purchase Agreement with Heritage Dialysis

WIXOM, Mich.--(BUSINESS WIRE)--Rockwell Medical will supply Heritage Dialysis with a portfolio of hemodialysis products including PureCart, RenalPure, SteriLyte and other products....
Back to Newsroom